2 completed, 1 suspended, 1 withdrawn. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Suspended 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Cataract Surgery: new trials by email Literature Review of Cataract Surgery trials Research Report on Cataract Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intracameral Antibiotic Safety Study Vancomycin, Moxifloxacin, Placebo - Intracameral Antibiotics, Cataract Surgery | Phase 3 | Suspended | Panhandle Eye Group, LLP | 500 | 2023-01-01 | 2022-04-27 |
| PREFERENTIAL Study Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE] - Cataract Surgery, Glaucoma Surgery | Phase 2 / Phase 3 | Withdrawn | Duke University | 2020-11-01 | 2021-11-17 | |
| Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery DE-108, Levofloxacin 0.5% - Cataract Surgery | Phase 3 | Completed | Santen Pharmaceutical Co., Ltd. | 576 | 2015-09-21 | 2017-10-12 |
| Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract Surgery Ster, Pred Fort - Inflammation, Cataract Surgery | Phase 3 | Completed | Azidus Brasil | 106 | 2011-01-01 | 2022-11-02 |
Cataract (1) · Endophthalmitis (1) · Inflammation (1)
Eye Diseases (2) · Eye Infections (1) · Infections (1) · Lens Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Calcium Dobesilate (1) · Levofloxacin (1) · Methylprednisolone (1) · Moxifloxacin (1) · Triclosan (1) · Vancomycin (1) · prednisolone acetate (1)
Azidus Brasil (1) · Duke University (1) · Panhandle Eye Group, LLP (1) · Santen Pharmaceutical Co., Ltd. (1)
Brazil (1) · South Korea (1) · United States (1)
Leon Herndon, MD (1)